Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 792 results found. Search for [ US health regulator ]

Results 40 to 60 of 792
BusinessToday.In
February 17, 2021
Stock Market News Updates Today: Nestle India, Titan, RIL, ITC, HUL, HCL Tech, ONGC, HDFC, TCS, PowerGrid and ICICI Bank were among the top losers today. On the other hand, Bajaj Auto, SBI, Bajaj Finance and Reliance Industries were among the gainers


BusinessToday.In
February 9, 2021
Stock Market News Updates Today: Sensex hit a record high of 51,753 and the Nifty hit a record high of 51,753 in early trade today. Both benchmark indices have gained over 11% in seven straight sessions


BusinessToday.In
February 8, 2021
Stock Market Live News Today: Sensex and Nifty continued hitting new all-time highs today. Both benchmarks hit fresh lifetime highs of 51,523 and 15,159 earlier today


BusinessToday.In
February 5, 2021
Cadila says its business in India, which comprises human health formulations, consumer wellness and animal health, posted strong growth during the quarter as it rose 20 per cent on a y-o-y basis and recorded revenues of Rs 1,643 crore


BusinessToday.In
February 1, 2021
Sensex, Nifty Highlights on Budget day, February 1: Almost all the sectors closed in green territory today, rising in the range of 3-6%, except for pharma index


Prasanna Mohanty
January 30, 2021
India has no data on jobs lost and businesses shut; no estimate of how many would have slipped into poverty or how income, health and education inequalities would have risen due to the pandemic. How will the Budget 2021 allocate resources appropriately to revive growth and bring development?


PTI
January 23, 2021
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory filing


Joe C Mathew
January 11, 2021
World Health Organization (WHO) chief scientist, Dr. Soumya Swaminathan's comments come in the backdrop of several Indian vaccine makers and medical experts complaining about the confusing manner in which DCGI has granted emergency use approvals for COVID-19 vaccines in India


PTI
January 10, 2021
The drug firm has manufactured the affected lot at its Kurkumbh facility in Maharashtra and then supplied to its New Jersey-based subsidiary


Associated Press
January 9, 2021
A major incident is defined as one in which there is a risk to life and welfare and is \"beyond the scope of business-as-usual operations. It allows coordination between different emergency agencies and will let London ask for help from other areas


Rashi Bisaria
New Delhi, January 7, 2021
US, UK warn Moderna, Pfizer vaccine may cause fever, weak immunity Debates continue in India whether the two COVID-19 vaccines that got emergency use authorisation from the country's drug regulator recently are safe and efficacious. The fact sheets for vaccine recipients in US and UK for Moderna and Pfizer-BioNTech vaccines say the vaccines are yet to be fully approved. Moderna's fact sheet for recipients says its vaccine is unapproved and 'may prevent COVID-19'. The UK government says it h...


Joe C Mathew
January 7, 2021
Fact sheets for recipients of Moderna and Pfizer-BioNTech vaccines in US and UK clarify that the vaccines are yet to be fully approved; recipients have been asked to get help if they experience severe side effects or allergic reactions


Team BT
New Delhi, January 6, 2021
How the FM can make it a 'never before' Budget. Top experts weigh in


PTI
January 5, 2021
This daunting challenge is not only for India but also for all the governments across the globe as they start inoculating their populations to tackle the pandemic, noted Dr Soumya Swaminathan, Chief Scientist of WHO


BusinessToday.In
New Delhi, January 4, 2021
With India set to roll out coronavirus vaccines, the Union Health Ministry has released a set of frequently -asked- questions related to the vaccines and the vaccination drive. India's drugs regulator on Sunday approved the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country. The Centre responded to queries about safety, side-effects,  anti-bodies etc. Watch the video for more.Also Read: DCGI approves Covaxin for children above 12 years, Covishield for above 18


BusinessToday.In
January 4, 2021
TCS, ONGC, SBI, L&T, Infosys, HCL Tech, ICICI Bank and Axis Bank were among the gainers. On the other hand, HDFC, Asian Paints and Reliance Industries were among the laggards


BusinessToday.In
January 4, 2021
The Brazilian Association of Vaccine Clinics (ABCVAC) confirmed on its website it had signed a memorandum of understanding with the Indian firm to purchase its vaccine


Manoj Sharma
December 31, 2020
Suffering poor financial health, Central government has not given a concrete answer on who will bear the cost of vaccinating Indians - Centre, states, or the people themselves


BusinessToday.In
December 30, 2020
The European Medicines Agency's  Deputy Executive Director Noel Wathion has said AstraZeneca and the University of Oxford have not filed an application for approval until now


Reuters
December 24, 2020
Brazil is the first country to complete a late-stage trial of the vaccine, called CoronaVac, but a release of the results, first set for early December, has now been delayed three times


PAGES 3 OF 40  12345